LONDON: The UK will explore ways to make obesity drugs more accessible to people outside hospital settings and cut NHS waiting lists in a new £40 million (US$50 million) two-year pilot programme, the government announced on Wednesday.While British prime minister Rishi Sunak has said cutting hospital waiting lists is one of his priorities, the National Health Service in England endured a tough winter, with waiting lists hitting record highs, and staff striking for higher pay amid double-digit inflation.The National Institute for Health and Care Excellence (NICE) is also considering potential NHS use of the drug Tirzepatide, which is “currently licensed to treat diabetes but if receives a lice
Hence then, the article about uk to explore wider access to obesity drugs in us 50m pilot was published today ( ) and is available onDaily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( UK to explore wider access to obesity drugs in US$50m pilot )